Cargando…
Muscle: an independent contributor to the neuromuscular spinal muscular atrophy disease phenotype
Spinal muscular atrophy (SMA) is a pediatric-onset neuromuscular disorder caused by insufficient survival motor neuron (SMN) protein. SMN restorative therapies are now approved for the treatment of SMA; however, they are not curative, likely due to a combination of imperfect treatment timing, inadeq...
Autores principales: | Jha, Narendra N., Kim, Jeong-Ki, Her, Yoon-Ra, Monani, Umrao R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561723/ https://www.ncbi.nlm.nih.gov/pubmed/37737261 http://dx.doi.org/10.1172/jci.insight.171878 |
Ejemplares similares
-
Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
por: Gollapalli, Kishore, et al.
Publicado: (2021) -
Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016) -
Limited Phenotypic Effects of Selectively Augmenting the SMN Protein in the Neurons of a Mouse Model of Severe Spinal Muscular Atrophy
por: Lee, Andrew J-H., et al.
Publicado: (2012) -
Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy
por: Montes, Jacqueline, et al.
Publicado: (2021) -
Smn, the spinal muscular atrophy–determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
por: Rossoll, Wilfried, et al.
Publicado: (2003)